– UK, Manchester – Renold PLC (LON: RNO), a leading international supplier of industrial chains and related power transmission products, today announced the appointment of Jim Haughey to the Board as the Group Finance Director. Jim’s start date is still to be finalised and an update will be made in due course.
“I am delighted to welcome Jim to the Group. Jim is a high calibre appointment with a proven track record across a range of senior finance functions within global industrial businesses,” said Mark Harper, Board Chairman.
Jim will replace Ian Scapens, who resigned as the Group’s Finance Director and is expected to leave the business after the investor roadshow to present the 2019/2020 annual results.
About Jim Haughey
Jim is currently UK Group Finance Director of Drive DeVilbiss Healthcare Limited, a manufacturer and global distributor of durable healthcare products.
Jim qualified as a Chartered Accountant in 1991 and has subsequently spent his career in senior finance roles across a range of industrial businesses including FKI, Bridon, Cosalt and Bodycote within line and central functions. He was Group Finance Director for AIM-listed Mpac Group plc, the global supplier of high-speed packaging and automation solutions.
About Renold Plc
Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.
For more information: https://www.renold.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.